ArticleCurrent medical science2018

Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases.

Shao-Bo Ke et al.PubMed ↗Publisher ↗

No numbers read from the abstract.